SEC Form 4 · accession 0001209191-15-032286
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan C. Herman
Officer — Chief Scientific Officer
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | holding | — | — | — | 214,699 | D | ||
| Common Stock, $0.0001 par valueF1,F2 | holding | — | — | — | 300,164 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $29.00 | Apr 1, 2015 | A | 50,000 | A | — | Mar 31, 2025 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1A portion of these shares is subject to a right of repurchase held by the Issuer.
- F2These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.
- F3The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from April 1, 2015, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.